| scholarly article | Q13442814 |
| P50 | author | Giuseppe La Torre | Q41290896 |
| Cristina Sestili | Q60330090 | ||
| P2093 | author name string | Alice Mannocci | |
| Vittoria Colamesta | |||
| Antonietta Spadea | |||
| Valeria D'Egidio | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Pneumococcal vaccines WHO position paper--2012 | Q28304059 | ||
| Influenza A/H1N1 in pediatric oncology patients. | Q30354663 | ||
| H1N1 pandemic influenza: habits and behaviour of the nurses. A public health issue. | Q30358181 | ||
| Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study | Q30369346 | ||
| Behaviours regarding preventive measures against pandemic H1N1 influenza among Italian healthcare workers, October 2009. | Q30383379 | ||
| Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host | Q30395200 | ||
| Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom | Q30396068 | ||
| Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment | Q30397613 | ||
| The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic | Q30398382 | ||
| The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies | Q30403660 | ||
| Knowledge, attitude, and behaviour of public health doctors towards pandemic influenza compared to the general population in Italy. | Q30408279 | ||
| Seasonal and pandemic influenza: the role of communication and preventive strategies | Q30408340 | ||
| Knowledge about pandemic flu among Italian health care workers (HCWs): an Italian survey | Q30408344 | ||
| Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment | Q30409034 | ||
| Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients. | Q30427666 | ||
| A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma | Q33360818 | ||
| The Italian alliance for vaccination strategies: Facebook as a learning tool for preventive medicine and public health | Q33723408 | ||
| Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report. | Q34704085 | ||
| Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. | Q34994903 | ||
| Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines | Q35231638 | ||
| Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT) | Q35623591 | ||
| Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation | Q36250895 | ||
| Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies | Q36355144 | ||
| Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. | Q36488282 | ||
| Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma | Q36641621 | ||
| Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies | Q36978418 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Immunological risk factors for infection after immunosuppressive and biologic therapies. | Q37866813 | ||
| Prevalence of influenza vaccination among nurses and ancillary workers in Italy: systematic review and meta analysis. | Q37894533 | ||
| Do the quality of the trials and the year of publication affect the efficacy of intervention to improve seasonal influenza vaccination among healthcare workers?: Results of a systematic review. | Q38071899 | ||
| Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease | Q39205728 | ||
| A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy | Q40755403 | ||
| The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses | Q42790878 | ||
| Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy | Q43174307 | ||
| Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation | Q43622125 | ||
| Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted? | Q43648723 | ||
| Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. | Q44088518 | ||
| Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma | Q44119335 | ||
| Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004. | Q44914270 | ||
| Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae | Q45731339 | ||
| Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients | Q45735659 | ||
| Effectiveness of a training course on influenza vaccination in changing medical students' and healthcare workers' attitudes towards vaccination | Q45846104 | ||
| Social marketing and public health | Q46936867 | ||
| Prevention of influenza: recommendations for influenza immunization of children, 2008-2009. | Q51869670 | ||
| Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines | Q52016324 | ||
| Serologic response to a 23-valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myeloma | Q58878983 | ||
| Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma | Q59298109 | ||
| Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy | Q59396766 | ||
| Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation | Q61835864 | ||
| Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease | Q62096710 | ||
| Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q64133551 | ||
| Pneumococcal vaccination in children with acute lymphocytic leukemia | Q69834839 | ||
| Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients | Q71408101 | ||
| A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT | Q71810592 | ||
| Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy | Q72770789 | ||
| Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma | Q73172466 | ||
| Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia | Q73414332 | ||
| Influenza among hospitalized adults with leukemia | Q73441192 | ||
| Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia | Q74263359 | ||
| Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia | Q75369403 | ||
| Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients | Q77462756 | ||
| Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma | Q79997612 | ||
| Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia | Q80133543 | ||
| Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases | Q81077914 | ||
| Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study | Q81896225 | ||
| Humoral response to conjugate pneumococcal vaccine in paediatric oncology patients | Q82616054 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | e2016044 | |
| P577 | publication date | 2016-09-01 | |
| P13046 | publication type of scholarly work | systematic review | Q1504425 |
| review article | Q7318358 | ||
| P1433 | published in | Mediterranean journal of hematology and infectious diseases | Q27723406 |
| P1476 | title | Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety | |
| P478 | volume | 8 |
| Q37677227 | H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016. |
| Q92402845 | Response to pneumococcal vaccination in multiple myeloma |
| Q41987062 | Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center. |
Search more.